Genetic mutations that inhibit hepcidin production or its binding to ferroportin are associated with systemic iron overload and hemochromatosis (74, 75), while mutations in hepcidin suppressors, such as matriptase-2, cause iron refractory iron deficiency anemia (IRIDA) (76, 77). The gene discussed is HAMP; the disease is IRIDA syndrome.